文献速递颈动脉与弓上血管

症状性颈动脉串联病变杂交血运重建的长期结局

Long-Term Outcome of Symptomatic Patients Undergoing Hybrid Revascularisation for Extracranial Carotid Artery Tandem Stenosis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-04-12

30天内无死亡、卒中或TIA,2例临床MI;中位随访73个月期间3例死亡,1例症状性再狭窄,2例发生同侧卒中及MI。结论认为杂交血运重建可行且安全,但长期不良事件数相对较高。

要点

  • 症状性颈动脉串联病变杂交手术30天内无死亡、卒中或TIA。
  • 中位随访73个月,3例死亡,1例症状性再狭窄,2例同侧卒中及MI。
  • 长期任何不良事件数相对较高,需权衡自然病程。

核心结论

  • 在小样本病例系列中,症状性颈动脉串联病变的杂交血运重建似乎可行且安全。
  • 长期数据显示任何不良事件的数量相对较高。
  • 这些手术结局需与症状性颈动脉串联病变患者的自然病程进行权衡。

研究设计与样本

  • 两中心回顾性筛选2003–2017年因症状性颈动脉狭窄行颈动脉内膜切除术的连续患者,检出颈动脉串联病变。
  • 所有患者每年临床复查包括双功超声。

主要发现

  • 30天内无死亡、卒中或TIA,2例患者发生临床MI。
  • 中位随访73个月(四分位距22–85个月)期间,3例患者死亡。
  • 1例患者发生ICA症状性再狭窄(同侧TIA)。
  • 2例(无再狭窄)发生同侧卒中及MI。

关键数值与推荐

  • 颈动脉串联病变定义为涉及颈内动脉和同侧颈总动脉或无名动脉的多节段显著(>50%)动脉粥样硬化病变。
  • 主要结局为30天内任何卒中、死亡、MI或TIA。
  • 次要结局为随访期间任何卒中、死亡、MI或TIA以及再狭窄≥50%的发生。

临床怎么用

  • 对于症状性颈动脉串联病变,杂交血运重建(近端逆行支架置入后CEA)可作为可行治疗选择。
  • 术后需长期随访监测再狭窄及不良事件。
  • 治疗决策需结合自然病程权衡长期不良事件风险。

局限性

  • 来自两中心,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Carotid tandem lesions are a multilevel significant (>50%) atherosclerotic disease involving both the internal carotid artery (ICA) and either the ipsilateral common carotid artery (CCA) or the innominate artery (IA). These lesions may be challenging to treat. Current guidelines offer no definitive recommendation on the optimal treatment algorithm. The aim of this analysis was to assess the long-term outcome of patients undergoing surgical revascularisation for tandem lesions. METHODS: In two centres, consecutive patients who underwent carotid endarterectomy (CEA) for a symptomatic carotid artery stenosis between 2003 and 2017 were screened retrospectively for the presence of a carotid artery tandem lesion. All eligible patients were treated by a hybrid approach, consisting of retrograde stenting of the proximal CCA or IA followed by CEA. All patients had a yearly clinical check up including duplex ultrasound. The primary outcome was occurrence of any stroke, death, myocardial infarction (MI), or transient ischaemic attack (TIA) within 30 days. Secondary outcomes were any stroke, death, MI, or TIA and occurrence of restenosis ≥50% during follow up. RESULTS: Sixteen of 2368 symptomatic patients were included. Besides a high grade ICA stenosis, patients had a significant ipsilateral stenosis of the CCA (n = 13) or IA (n = 3). Within 30 days there were no deaths, strokes, or TIAs. Two patients had a clinical MI. During a median follow up of 73 (interquartile range 22-85) months, three patients died. One patient developed a symptomatic restenosis of the ICA (ipsilateral TIA). Two patients (without restenosis) developed an ipsilateral stroke and a MI. CONCLUSIONS: In this small case series, hybrid revascularisation of carotid tandem lesions in symptomatic patients seems feasible and safe. Long-term data show a relatively high number of any adverse events. These surgical outcomes need to be offset against the natural course in patients with a symptomatic carotid tandem lesion.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Meershoek AJA, Velde HM, Toorop RJ, et al. Long-Term Outcome of Symptomatic Patients Undergoing Hybrid Revascularisation for Extracranial Carotid Artery Tandem Stenosis. Eur J Vasc Endovasc Surg. 2019. PMID: 30987818. doi:10.1016/j.ejvs.2018.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。